Hao Ding et al. found that PDE2A might be a biomarker for early diagnosis and prognosis evaluation of cervical squamous cell carcinoma and endocervical adenocarcinoma patients [23]. The gene discussed is PDE2A; the disease is endocervical adenocarcinoma.